Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015;10(15):2379-404.
doi: 10.2217/nnm.15.67.

Antimicrobial photodynamic inactivation in nanomedicine: small light strides against bad bugs

Affiliations
Review

Antimicrobial photodynamic inactivation in nanomedicine: small light strides against bad bugs

Rui Yin et al. Nanomedicine (Lond). 2015.

Retraction in

  • Retraction.
    [No authors listed] [No authors listed] Nanomedicine (Lond). 2023 Mar;18(6):577. doi: 10.2217/nnm.15.67r1. Epub 2022 Apr 27. Nanomedicine (Lond). 2023. PMID: 35473367 Free PMC article. No abstract available.

Abstract

The relentless advance of drug-resistance among pathogenic microbes, mandates a search for alternative approaches that will not cause resistance. Photodynamic inactivation (PDI) involves the combination of nontoxic dyes with harmless visible light to produce reactive oxygen species that can selectively kill microbial cells. PDI can be broad-spectrum in nature and can also destroy microbial cells in biofilms. Many different kinds of nanoparticles have been studied to potentiate antimicrobial PDI by improving photosensitizer solubility, photochemistry, photophysics and targeting. This review will cover photocatalytic disinfection with titania nanoparticles, carbon nanomaterials (fullerenes, carbon nanotubes and graphene), liposomes and polymeric nanoparticles. Natural polymers (chitosan and cellulose), gold and silver plasmonic nanoparticles, mesoporous silica, magnetic and upconverting nanoparticles have all been used for PDI.

Keywords: bacteria; carbon nanomaterials; fungi; liposomes; photodynamic therapy; photoinactivation; photosensitizer; titania photocatalysis; upconversion.

PubMed Disclaimer

Conflict of interest statement

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript.

No writing assistance was utilized in the production of this manuscript.

Figures

Figure 1
Figure 1. Jablonski diagram
Ground state photosensitizer (0PS) absorbs light to form first excited singlet state (1PS) that (in addition to losing energy by fluorescence or conversion to heat) undergoes intersystem crossing to form the long lived first excited triplet state (3PS). The triplet state can undergo type 1 (electron transfer) photochemical reaction to form superoxide and hydroxyl radical, and/or type 2 (energy transfer) photochemical reaction to form singlet oxygen. These ROS can oxidatively damage and kill all known forms of microorganism. hνabs: Absorbed light; hvem: Emitted light; IC: Internal conversion; ISC: Intersyetem crossing; ROS: Reactive oxygen species; PS: Photosensitizer.
Figure 2
Figure 2. Gram-positive and Gram-negative cell walls
(A) Gram-negative bacteria have a double lipid bilayer (inner and outer membrane) separated by periplasm and peptidoglycan. The outer membrane contains porins and lipoproteins and is decorated with lipopolysaccharide chains with a negative charge. (B) Gram-positive bacteria have a single lipid bilayer surrounded by a thick but porous layer of peptidoglycan, with teichuronic and lipoteichoic acids providing a negative charge.
Figure 3
Figure 3. Nanoparticles that have been covalently modified with photosensitizers
(A) Dendrimers conjugated to PS. (B) Macromolecules with biotargeting properties such as antibodies. (C) Lipid-conjugated PS self-assemble into liposomes. (D) Solid nanoparticles can be conjugated to PS. PS: Photosensitizer.
Figure 4
Figure 4. Noncovalent encapsulation of photosensitizers
Polymeric nanoparticles are sub-µm colloidal particles designed to solubilize hydrophobic photosensitizer. They include: (A) nanomicelles in which amphiphilic copolymers with hydrophobic and hydrophilic blocks self-assemble to entrap the cargo; (B) nanocapsules, in which the cargo is in solution and surrounded by a shell-like wall; (C) nanospheres, in which the cargo is dissolved, adsorbed or dispersed throughout the matrix, attached to the surface or attached to the polymer matrix; and (D) liposomes in which an amphiphlic polymer self-assembles into a lipid bilayer that forms a unilamellar vesicle that encapsulates the cargo [50].
Figure 5
Figure 5. Titania photocatalysis
Schematic illustration of main processes in the photocatalytic reaction of TiO2. Nanoparticles have a sufficiently large surface area to allow this process to be efficient. Electrons are excited by UVA light from the semiconductor valence band to the conductance band. The electrons in the conductance band undergo electron transfer to oxygen to form superoxide, and the holes in the valence band react with water to form hydroxyl radicals. The ROS produced (O2·− and HO·) can kill microorganisms. CB: Conduction band; Eg: Energy gap; UVA: Ultraviolet A; VB: Valence band.
Figure 6
Figure 6. Fullerenes used in antimicrobial photodynamic therapy
(A) The tri-cationic C60 fullerene BF6. (B) The deca-cationic C60 fullerene, C60[>M(C3N6+C3)2]. (C) The deca-cationic C70 fullerene, C70[>M(C3N6+C3)2].
Figure 7
Figure 7. Carbon nanotubes
(A) Multiwalled carbon nanotubes. (B) Single-walled arbon nanotubes.
Figure 8
Figure 8. Titanium dioxide coated carbon nanotubes
The vertical array of multiwalled carbon nanotubes acts as a filter for bacterial retention while TiO2 acts as a bactericidal photocatalyst.
Figure 9
Figure 9. Graphene-loaded photosensitizers
(A) Hydrophobic photosensitizer can be ‘sandwiched’ between graphene sheets by π–π stacking. Examples of photosensitizer that have been loaded on to graphene are: (B) HPPH; (C) hypocrellin a; (D) methylene blue. HPPH: 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a.
Figure 10
Figure 10. Chemical structure of antimicrobial photosensitizers
(A) 5-[4-(1-dodecanoylpyridinium)]-10,15,20-triphenyl-porphyrin; (B) m-tetrahydroxyphenyl-chlorin; (C) chlorin(e6); (D) hypericin; (E) methylene blue; (F) Rose Bengal; (G) CNC-Por(1); (H) toluidine blue O; (I) 5,15-bisphenyl-10,20-bis(4-methoxycarbonylphenyl)- porphyrin] platinum (t-PtCP); (J) Zn-phthalocyanine.
Figure 11
Figure 11. Naturally occurring biopolymers used to form nanoparticles
(A) Chitosan. (B) Cellullose.
Figure 12
Figure 12. Gold nanoparticle-conjugated photosensitizer
(A) Gold nanoshell encapsulating a PS. (B) Plasmonic gold nanoparticle. The local electric field caused by conductance electrons potentiates the optical field close to the surface and increases the fluorescence or photoactivity of an attached PS. PS: Photosensitizer.
Figure 13
Figure 13. Magnetic nanoparticle-conjugated photosensitizer
Consists of a magnetite core (Fe3O4) coated by a biologically compatible layer such as PEG, and the PS are covalently attached by flexible linkers. PS: Photosensitizer.
Figure 14
Figure 14. Upconverting nanoparticle-mediated photodynamic therapy
Nanoparticles made of rare earth salts such as NaYF4 absorb continuous wavelength 980-nm light and emit 490-nm light that can excite a conjugated PS. PS: Photosensitizer.

Similar articles

Cited by

References

    1. Guyer B, Freedman MA, Strobino DM, Sondik EJ. Annual summary of vital statistics: trends in the health of Americans during the 20th century. Pediatrics. 2000;106(6):1307–1317. - PubMed
    1. Fauci AS, Morens DM. The perpetual challenge of infectious diseases. N. Engl. J. Med. 2012;366(5):454–461. - PubMed
    1. Youngblood WJ, Gryko DT, Lammi RK, Bocian DF, Holten D, Lindsey JS. Glaser-mediated synthesis and photophysical characterization of diphenylbutadiyne-linked porphyrin dyads. J. Org. Chem. 2002;67(7):2111–2117. - PubMed
    1. Smith R, Coast J. The true cost of antimicrobial resistance. Br. Med. J. 2013;346:f1493. - PubMed
    1. Kraus CN. Low hanging fruit in infectious disease drug development. Curr. Opin. Microbiol. 2008;11(5):434–438. - PubMed

LinkOut - more resources